Pharmacological suppression of the WNT signaling pathway attenuates age-dependent expression of the phenotype in a mouse model of arrhythmogenic cardiomyopathy

Abstract

Introduction: Arrhythmogenic cardiomyopathy (ACM) is a genetic disease of the myocardium, characterized by cardiac arrhythmias, dysfunction, and sudden cardiac death. The pathological hallmark of ACM is fibro-adipocytes replacing cardiac myocytes. The canonical WNT pathway is implicated in the pathogenesis of ACM.

Aim: The study aimed to determine the effects of the suppression of the WNT pathway on cardiac phenotype in a mouse model of ACM.

Methods and Results: One copy of the Dsp gene, a known cause of ACM in humans, was deleted specifically in cardiac myocytes (Myh6-Cre-Dsp^W/F). Three-month-old wild type and Myh6-Cre-Dsp^W/F mice, without a discernible phenotype, were randomized to either untreated or daily administration of a vehicle (placebo), or WNT974, the latter an established inhibitor of the WNT pathway, for three months. The Myh6-Cre-Dsp^W/F mice in the untreated or placebo-treated groups exhibited cardiac dilatation and dysfunction, increased myocardial fibrosis, and apoptosis upon completion of the study, which was verified by complementary methods. Daily administration of WNT974 prevented and/or attenuated evolving cardiac dilatation and dysfunction, normalized myocardial fibrosis, and reduced apoptosis, compared to the untreated or placebo-treated groups. However, administration of WNT974 increased the number of adipocytes only in the Myh6-Cre-Dsp^W/F hearts. There were no differences in the incidence of cardiac arrhythmias and survival rates.

Conclusion: Suppression of the WNT pathway imparts salutary phenotypic effects by preventing or attenuating age-dependent expression of cardiac dilatation and dysfunction, myocardial fibrosis, and apoptosis in a mouse model of ACM. The findings set the stage for large-scale studies and studies in larger animal models to test the beneficial effects of the suppression of the WNT pathway in ACM.

One sentence summary: Suppression of the WNT signaling pathway has beneficial effects on cardiac dysfunction, myocardial apoptosis, and fibrosis in a mouse model of arrhythmogenic cardiomyopathy.

Keywords

Cardiomyopathy / WNT signaling / fibrosis / apoptosis / heart failure

References

[1] Corrado D,Calkins H.Arrhythmogenic right ventricular cardiomyopathy.N Engl J Med2017;376:61-72

[2] Corrado D,Thiene G.Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study.J Am Coll Cardiol1997;30:1512-20

[3] Marcus FI,Guiraudon G., Right ventricular dysplasia: a report of 24 adult cases.Circulation1982;65:384-98

[4] Basso C,Corrado D,Nava A.Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis?.Circulation1996;94:983-91

[5] Sen-Chowdhry S,Prasad SK.Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity.J Am Coll Cardiol2008;52:2175-87

[6] McKoy G,Crosby A.Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease).Lancet2000;355:2119-24

[7] Rampazzo A,Malacrida S.Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy.Am J Hum Genet2002;71:1200-6 PMCID:PMC385098

[8] Gerull B,Wichter T.Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy.Nat Genet2004;36:1162-4

[9] Heuser A,Ellinor PT.Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy.Am J Hum Genet2006;79:1081-8 PMCID:PMC1698714

[10] Pilichou K,Basso C.Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy.Circulation2006;113:1171-9

[11] Smith ED,Papoutsidakis N.Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy.Circulation2020;141:1872-84 PMCID:PMC7286080

[12] Mayosi BM,Shaboodien G.Identification of cadherin 2 (CDH2) mutations in arrhythmogenic right ventricular cardiomyopathy.Circ Cardiovasc Genet2017;10:e001605

[13] van Hengel J,Bauce B.Mutations in the area composita protein alphaT-catenin are associated with arrhythmogenic right ventricular cardiomyopathy.Eur Heart J2013;34:201-10

[14] Ortiz-Genga MF,Dal Ferro M.Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies.J Am Coll Cardiol2016;68:2440-51

[15] van der Zwaag PA,Asimaki A.Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy.Eur J Heart Fail2012;14:1199-207 PMCID:PMC3475434

[16] Parikh VN,Reuter C.Regional variation in RBM20 causes a highly penetrant arrhythmogenic cardiomyopathy.Circ Heart Fail2019;12:e005371 PMCID:PMC6422044

[17] Quarta G,Ashworth M.Mutations in the lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy.Eur Heart J2012;33:1128-36

[18] Merner ND,Haywood AF.Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene.Am J Hum Genet2008;82:809-21 PMCID:PMC2427209

[19] Broussard JA,Green KJ.Desmosome regulation and signaling in disease.Cell Tissue Res2015;360:501-12 PMCID:PMC4489137

[20] Manring HR,Ex-Willey A,Ackermann MA.At the heart of inter- and intracellular signaling: the intercalated disc.Biophys Rev2018;10:961-971 PMCID:PMC6082301

[21] Garcia-Gras E,Giocondo MJ.Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy.J Clin Invest2006;116:2012-21 PMCID:PMC1483165

[22] Chen SN,Lombardi R,Willerson JT.The hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy.Circ Res2014;114:454-68 PMCID:PMC3946717

[23] Hall CL,Sabater-Molina M.RNA sequencing-based transcriptome profiling of cardiac tissue implicates novel putative disease mechanisms in FLNC-associated arrhythmogenic cardiomyopathy.Int J Cardiol2020;302:124-30 PMCID:PMC6940594

[24] Puzzi L,Gurha P.Knock down of plakophillin 2 dysregulates adhesion pathway through upregulation of miR200b and alters the mechanical properties in cardiac cells.Cells2019;8:1639 PMCID:PMC6952926

[25] Lombardi R,Bell A,Willerson JT.Nuclear plakoglobin is essential for differentiation of cardiac progenitor cells to adipocytes in arrhythmogenic right ventricular cardiomyopathy.Circ Res2011;109:1342-53 PMCID:PMC3237769

[26] Lombardi R,Ruggiero A.Cardiac fibro-adipocyte progenitors express desmosome proteins and preferentially differentiate to adipocytes upon deletion of the desmoplakin gene.Circ Res2016;119:41-54 PMCID:PMC4920717

[27] Lombardi R,Rodriguez G.Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy.Circ Res2009;104:1076-84 PMCID:PMC2767296

[28] Asimaki A,Plovie E.Identification of a new modulator of the intercalated disc in a zebrafish model of arrhythmogenic cardiomyopathy.Sci Transl Med2014;6:240ra74 PMCID:PMC4471875

[29] Chelko SP,Andersen P.Central role for GSK3beta in the pathogenesis of arrhythmogenic cardiomyopathy.JCI Insight2016;1:e85923 PMCID:PMC4861310

[30] Cheedipudi SM,Fan S.Exercise restores dysregulated gene expression in a mouse model of arrhythmogenic cardiomyopathy.Cardiovasc Res2020;116:1199-1213 PMCID:PMC7177479

[31] Cheedipudi SM,Coarfa C.Genomic reorganization of lamin-associated domains in cardiac myocytes is associated with differential gene expression and DNA methylation in human dilated cardiomyopathy.Circ Res2019;124:1198-1213 PMCID:PMC6459729

[32] Liu J,Hsieh MH.Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974.Proc Natl Acad Sci U S A2013;110:20224-9 PMCID:PMC3864356

[33] Moon J,Zhang LS.Blockade to pathological remodeling of infarcted heart tissue using a porcupine antagonist.Proc Natl Acad Sci U S A2017;114:1649-54 PMCID:PMC5320972

[34] Auguste G,Lombardi R,Willerson JT.Suppression of activated FOXO transcription factors in the heart prolongs survival in a mouse model of laminopathies.Circ Res2018;122:678-92 PMCID:PMC5834384

[35] Auguste G,Matkovich SJ.BET bromodomain inhibition attenuates cardiac phenotype in myocyte-specific lamin A/C-deficient mice.J Clin Invest2020;130:4740-58 PMCID:PMC7456228

[36] Rouhi L,Chen SN.Haplo-insufficiency of Tmem43 in cardiac myocytes activates the DNA damage response pathway leading to a Late-Onset Senescence-Associated pro-fibrotic cardiomyopathy.Cardiovasc Res2020;cvaa300

[37] Bergmann O.Isolation of cardiomyocyte nuclei from post-mortem tissue.J Vis Exp2012;4205 PMCID:PMC3476409

[38] Bergmann O,Alkass K,Bernard S.Identification of cardiomyocyte nuclei and assessment of ploidy for the analysis of cell turnover.Exp Cell Res2011;317:188-94

[39] Ross SE,Longo KA.Inhibition of adipogenesis by Wnt signaling.Science2000;289:950-3

[40] Xiang FL,Yutzey KE.Loss of beta-catenin in resident cardiac fibroblasts attenuates fibrosis induced by pressure overload in mice.Nat Commun2017;8:712 PMCID:PMC5620049

[41] Daskalopoulos EP.Effect of interventions in WNT signaling on healing of cardiac injury: a systematic review.Cells2021;10:207 PMCID:PMC7912185

[42] Padrón-Barthe L,Gómez-Salinero JM.Severe cardiac dysfunction and death caused by arrhythmogenic right ventricular cardiomyopathy type 5 are improved by inhibition of glycogen synthase kinase-3beta.Circulation2019;140:1188-204 PMCID:PMC6784777

[43] Hariharan V,Michaelson JE.Arrhythmogenic right ventricular cardiomyopathy mutations alter shear response without changes in cell-cell adhesion.Cardiovasc Res2014;104:280-9 PMCID:PMC4296114

[44] Beurel E,Jope RS.Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.Pharmacol Ther2015;148:114-31 PMCID:PMC4340754